ApoB quantification is especially useful in patients with insulin resistance and elevated triglyceride levels above 150 mg/dL, where the Friedewald equation becomes inaccurate and loses its ability to provide a measure of atherogenic load [80,81,82,83,175,176]. Here, APOB is linked to Insulin resistance.